Raymond James Financial Services Advisors, Inc. Exact Sciences Corp Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 13,029 shares of EXAS stock, worth $757,115. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,029
Previous 12,571
3.64%
Holding current value
$757,115
Previous $531,000
67.04%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding EXAS
# of Institutions
673Shares Held
162MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.03 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$921 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$833 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$701 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$388 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.3B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...